Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017 by Véronique Etienne, CNRS

Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded by modification of MAIT lymphocytes. These cells—associated with mucosae and able to recognize elements of the microbiota—could therefore serve as new biomarkers for early detection and prevention of the illness. The researchers' findings are published in Nature Immunology.

Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. Yet the innate immune system, our body's first line of defense, also plays an important role in this disease. MAIT associated with the mucosae are an integral part of this front-line immunity. They are activated by bacteria—especially those of the intestinal flora, or . The research team wondered what role MAIT cells played in the T1D-related disturbance of this flora and of gut mucosal homeostasis.

Investigations, led by Agnès Lehuen relied on T1D animal models studied by her team at the Cohin Institute as well as blood samples from patients under the care of Dr. Jacques Beltrand from the Necker–Enfants Malades Hospital. Findings for both the samples and the animal models showed that MAIT cells are altered before T1D develops. When T1D is diagnosed in children, the number of MAIT cells in their blood is lower than in nondiabetic children. Migration of MAIT cells to inflamed pancreatic tissue in T1D patients could explain the discrepancy. This is a very reasonable assumption since the pancreatic population of MAIT cells swells in nonobese diabetic (NOD) mice. (NOD mice develop a form of diabetes very similar to the human disease.) Furthermore, experiments performed by the researchers on in vitro and on NOD mice suggest MAIT cells are directly linked to the destruction of .

In addition to changes in their concentration and location within the body, it appears that a functional defect in MAIT cells is linked to the modifications of the gut mucosa seen in T1D patients. Indeed, a normal function of MAIT cells is to maintain the homeostasis of this mucosa. This capacity is compromised in T1D, making the gut mucosa permeable to bacteria, which, in turn, favors an autoimmune response. Ongoing research seeks to better understand the links between MAIT cells and the gut microbiota.

The team's discovery could lead to the development of new strategies for T1D treatment. Most importantly, we now know that MAIT cells are early biomarkers for this form of diabetes because they undergo changes before the disease develops. Their use as such should improve T1D prevention.

Explore further: T cell population altered in patients with type 2 diabetes and/or obesity

More information: Ophélie Rouxel et al. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes, Nature Immunology (2017). DOI: 10.1038/ni.3854

Related Stories

T cell population altered in patients with type 2 diabetes and/or obesity

March 9, 2015
As obesity rates rise, so does the incidence of type 2 diabetes (T2D). In obese individuals and those with obesity-induced T2D, there is an accumulation of immune cells within adipose tissue that results in a low level of ...

Bacterial superantigens turn our immune cells to the dark side

June 20, 2017
A subpopulation of immune cells that normally fend off pathogens can turn against the host during certain infections, a new study publishing on June 20 in the open access journal PLOS Biology reveals.

Research shows extremely limited diversity among one group of immune cells and uncovers a new population

November 19, 2014
In an investigation of a specific group of immune cells, researchers at A*STAR identified a limited repertoire of receptors that recognize bacterial targets. This finding led to the further discovery of a previously undetected ...

Unearthing immune responses to common drugs

February 6, 2017
Australian researchers are a step closer to understanding immune sensitivities to well-known, and commonly prescribed, medications.

Researchers find more uses for immune system's 'Swiss army knife'

June 23, 2016
Oxford University research has found that a little-studied and relatively unknown part of the human immune system could be twice as important as previously thought.

Salmonella research improves understanding of immune defence

November 29, 2012
Australian researchers have discovered that vitamin B metabolites produced by Salmonella bacteria can activate the immune system, a finding that could lead to new treatments for gut and lung diseases.

Recommended for you

Switching to certain antidiabetic drugs linked to increased risk of major complications

July 18, 2018
For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds a study in The BMJ today.

Researchers cure type 2 diabetes and obesity in mice using gene therapy

July 10, 2018
A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy

July 9, 2018
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent ...

New targets found to reduce blood vessel damage in diabetes

July 9, 2018
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature.

Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes

July 9, 2018
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an ...

Abnormal branched-chain amino acid breakdown may raise diabetes risk

July 5, 2018
In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus (GDM), a temporary form of diabetes in which hormonal changes disrupt insulin function. Although GDM is often symptomless and subsides ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.